Get the Stockscreener App
83.51
0.91%
0.75
After Hours:
83.51
Arcellx Inc stock is traded at $83.51, with a volume of 514.09K.
It is up +0.91% in the last 24 hours and up +21.49% over the past month.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
See More
Previous Close:
$82.76
Open:
$82.83
24h Volume:
514.09K
Relative Volume:
1.14
Market Cap:
$4.49B
Revenue:
$144.75M
Net Income/Loss:
$-53.89M
P/E Ratio:
-21.09
EPS:
-3.96
Net Cash Flow:
$-42.88M
1W Performance:
-2.87%
1M Performance:
+21.49%
6M Performance:
+20.07%
1Y Performance:
+132.75%
1-Day Range:
$81.66
$86.40
1-Week Range:
$81.66
$86.40
52-Week Range:
$30.88
$88.66
Arcellx Inc Stock (ACLX) Company Profile
Name
Arcellx Inc
Sector
Industry
Phone
240-327-0603
Address
800 BRIDGE PARKWAY, REDWOOD CITY
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-04-24 | Reiterated | Needham | Buy |
| Dec-19-23 | Initiated | Scotiabank | Sector Outperform |
| Oct-30-23 | Initiated | TD Cowen | Outperform |
| Oct-17-23 | Initiated | UBS | Buy |
| May-18-23 | Initiated | Truist | Buy |
| Apr-14-23 | Initiated | Robert W. Baird | Outperform |
| Mar-14-23 | Initiated | Stifel | Buy |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-13-22 | Resumed | BofA Securities | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-27-22 | Initiated | Needham | Buy |
| Jul-20-22 | Initiated | Canaccord Genuity | Buy |
| Mar-01-22 | Initiated | BofA Securities | Buy |
| Mar-01-22 | Initiated | SVB Leerink | Outperform |
View All
Arcellx Inc Stock (ACLX) Latest News
Arcellx, Inc. (NASDAQ:ACLX) Position Lessened by Perceptive Advisors LLC - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Short Interest Update - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Short Interest Update - Defense World
(ACLX) Investment Report - Stock Traders Daily
Wall Street SWOT: Arcellx stock rides wave of innovation in cell therapy market - Investing.com
Wall Street SWOT: Arcellx stock rides wave of innovation in cell therapy market - Investing.com India
Arcellx, Inc. (NASDAQ:ACLX) Receives $78.00 Consensus Target Price from Brokerages - MarketBeat
1,177 Shares in Arcellx, Inc. (NASDAQ:ACLX) Acquired by Decheng Capital LLC - Defense World
State of New Jersey Common Pension Fund D Buys New Stake in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcellx Inc [ACLX] Stock sold by Insider Gilson Michelle for $1.17 million - Knox Daily
Affinity Asset Advisors LLC Has $25.39 Million Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx Inc (ACLX)’s stock price in review: A technical analysis - US Post News
Arcellx, Inc. (NASDAQ:ACLX) Stock Position Decreased by Profund Advisors LLC - Defense World
Federated Hermes Inc. Sells 225,928 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Federated Hermes Inc. Sells 225,928 Shares of Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcutis Biotherapeutics Inc [ARQT] Stock sold by Insider Welgus Howard G. for $0.11 million - Knox Daily
Here's Why Ares Capital (ARCC) Gained But Lagged the Market Today - Yahoo Finance
ALXO stock touches 52-week low at $1.87 amid market challenges - Investing.com
Ares Capital (NASDAQ:ARCC) Shares Up 0.3% - Defense World
Ardelyx Inc [ARDX] Insider Rosenbaum David P. sells 5,312 Shares – Company Insider Activity - Knox Daily
Great Point Partners LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Aristeia Capital L.L.C. Buys Shares of 9,740 Alarm.com Holdings, Inc. (NASDAQ:ALRM) - MarketBeat
Great Point Partners LLC Increases Stake in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Berkley W R Corp Purchases New Shares in Alchemy Investments Acquisition Corp 1 (NASDAQ:ALCY) - MarketBeat
Accuray Inc [ARAY] Pervaiz Ali sells 8,404 Shares for $17276.0 - Knox Daily
Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily
Ares Capital (ARCC) Rises Higher Than Market: Key Facts - Yahoo Finance
Integral Health Asset Management LLC Buys 20,000 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Ares Capital (NASDAQ:ARCC) Trading 0.2% Higher - MarketBeat
Integral Health Asset Management LLC Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Market Update: Alx Oncology Holdings Inc (ALXO) Sees Negative Movement, Closing at 2.07 - The Dwinnex
Wall Street analysts’ outlook for Arcellx Inc (ACLX) - SETE News
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by HighVista Strategies LLC - Defense World
Gaining Ground: Arq Inc (ARQ) Closes Lower at 5.10, Down -17.34 - The Dwinnex
Get in on Aldeyra Therapeutics Inc’s (ALDX) buy-in window today! - SETE News
Brighton Jones LLC Makes New Investment in Arch Capital Group Ltd. (NASDAQ:ACGL) - Defense World
Arcus Biosciences Looks Compelling Ahead Of Key Clinical Oncology Milestones - Seeking Alpha
Blair William & Co. IL Sells 12,528 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World
Renaissance Technologies LLC Sells 800 Shares of Alexander’s, Inc. (NYSE:ALX) - Defense World
Brighton Jones LLC Lowers Stock Holdings in Lam Research Co. (NASDAQ:LRCX) - Defense World
Skandinaviska Enskilda Banken AB publ Boosts Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Defense World
Quest Partners LLC Invests $27,000 in Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Merriman Wealth Management LLC Purchases 1,144 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World
Acadian Asset Management LLC Takes Position in Albertsons Companies, Inc. (NYSE:ACI) - Defense World
Skandinaviska Enskilda Banken AB publ Has $25.97 Million Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - MarketBeat
Renaissance Technologies LLC Sells 15,500 Shares of Arch Resources, Inc. (NYSE:ARCH) - Defense World
Can you now get a good deal on Arcellx Inc’s shares? - US Post News
Arq Shares Fall 9% After Public Offering News - MarketWatch
CHIEF FINANCIAL OFFICER Gilson Michelle sale 15,000 shares of Arcellx Inc [ACLX] - Knox Daily
Acelyrin (NASDAQ:SLRN) Shares Gap Up to $4.60 - MarketBeat
A Deep Dive into Arcellx Inc (ACLX) Stock Performance - The InvestChronicle
Arcellx Inc Stock (ACLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):